Menu
Recruiting NCT06471504

Use of Eye Tracking to Aid in Autism Risk Detection

No phase Interventional Autism

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Eyelink Portable Duo.
Who it may be relevant to
Registry conditions: Autism. Basic parameters: 12 months — 48 months · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.

Detailed description

The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series (less than 15 mins) of eye-tracking measures (e.g., looking time, pupil diameter, oculomotor dynamics), which may be associated with autism in young children ages 12-48 months. We will recruit children from Riley Hospital for Children at Indiana University Health clinics to determine whether these measures may help determine autism risk.

Interventions

  • Diagnostic test Eyelink Portable Duo
    Eye-tracking data will be collected using a commercially-available remote eye-tracking system (Eyelink Portable Duo). Eye movements and pupil diameter will be collected while participants view a series of developmentally appropriate pictures and movies. The eye-tracker consists of two cameras; one that monitors eye movements and a second scene camera that monitors head movements, which permits eye tracking to take place without any equipment touching the child. Children will be asked to sit in h

Primary outcome measures

  • Agreement between eye-tracking biomarker score and diagnosis [Time frame: Day 1]

Eligibility criteria

Inclusion criteria

  • Young children ages 12-48 months scheduled for health care visits at Riley Hospital for Children at Indiana University Health clinics (e.g., Pediatric Care Center clinics).
  • Children must have English- or Spanish-speaking caregivers.
  • Children must have a legal guardian that is able to provide consent.

Exclusion criteria

  • Child is younger than 12 months or older than 48 months.
  • Child's caregiver(s) is not English- or Spanish-speaking.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

United States · 1 center
  • Riley Hospital for Children — Indianapolis

Identifiers

NCT: NCT06471504 · 21697

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗